Minimally Invasive Glaucoma Surgeries (MIGS)
What is Glaucoma?
Glaucoma is a group of eye diseases that damage the optic nerve, the vital connection between your eye and brain. It is often called the silent thief of sight because it can cause permanent vision loss without early warning signs, making early detection and treatment critical to preserving your eyesight.
This is the most common type, affecting millions of Americans. It develops slowly when the eye's drainage system becomes less efficient over time, causing fluid to build up and pressure to increase. Most people don't notice symptoms until significant vision loss has already occurred, which is why regular comprehensive eye exams are so important for catching this condition early.
This less common type happens when the drainage angle becomes completely blocked, causing a sudden, severe increase in eye pressure. Symptoms include intense eye pain, severe headaches, nausea, vomiting, and blurred vision with halos around lights. This is a medical emergency that requires immediate treatment to prevent permanent vision loss.
Some cases develop as a result of other eye conditions, eye injuries, certain medications like steroids, or medical problems such as diabetes and inflammatory conditions. Understanding the underlying cause helps your doctor guide treatment decisions and create a personalized care plan that addresses both the glaucoma and its root cause.
In some patients, optic nerve damage occurs even when eye pressure remains in the normal range. This type requires careful monitoring and treatment to prevent progression, as traditional pressure measurements alone may not reveal the full picture of your eye health.
Major risk factors include age over 60, a family history of glaucoma, African American or Hispanic heritage, high nearsightedness, thin corneas, previous eye injuries, and systemic conditions like diabetes and high blood pressure. Long-term steroid use and a history of eye trauma also increase your risk. Regular eye exams can identify these risks and allow for early intervention before vision loss begins.
Early stages of glaucoma often have no symptoms, but as the disease progresses, you may experience patchy blind spots in your peripheral or side vision, tunnel vision, difficulty adjusting to darkness, or halos around lights. If you notice any sudden vision changes, severe eye pain, headaches with nausea, or red eyes with blurred vision, contact your eye care provider right away.
Some symptoms of glaucoma can overlap with other eye problems, such as cataracts, macular degeneration, or diabetic retinopathy. Only a comprehensive eye exam with specialized testing like visual field analysis and optic nerve imaging can accurately diagnose glaucoma and distinguish it from these conditions, which is why early evaluation is key to protecting your vision.
Understanding MIGS
MIGS procedures use specialized microscopic tools and techniques to improve the eye's natural drainage system, offering a gentler approach to glaucoma surgery. They represent a modern alternative to more invasive surgeries, offering hope and improved outcomes for many patients with mild to moderate glaucoma.
Your eye constantly produces a clear fluid called aqueous humor that nourishes the cornea and lens while maintaining proper eye shape and pressure. This fluid normally drains out through a network of tiny channels called the trabecular meshwork, located in the angle where the iris meets the cornea. When this drainage becomes blocked or less efficient, pressure builds up inside the eye, potentially damaging the delicate optic nerve fibers that carry visual information to your brain.
Traditional glaucoma surgeries like trabeculectomy and tube shunt procedures require larger incisions, create new drainage pathways outside the eye, involve longer operating times, and need extended recovery periods with more intensive follow-up care. MIGS, by contrast, uses micro-devices and microscopic incisions that work within the eye's natural anatomy, minimizing tissue disruption and surgical risk, which often makes it a preferred option for mild to moderate cases.
MIGS is frequently performed at the same time as cataract surgery, providing a convenient, combined approach that addresses both conditions in a single procedure. Clinical studies show MIGS can lower eye pressure by 20 to 30 percent and reduce medication dependence in patients with mild to moderate glaucoma, without the higher risks of major surgery. This makes it an excellent option for patients who want to reduce their reliance on daily eye drops or who have not achieved adequate pressure control with medications alone.
Modern MIGS procedures rely on advanced surgical microscopes, specialized instruments, and innovative implant designs that are among the smallest medical devices ever created. At ReFocus Eye Health Cheshire, our ophthalmologists use the latest technology and techniques to ensure precise, safe outcomes for patients throughout Cheshire, Wallingford, Southington, and the surrounding communities.
Patients typically report minimal discomfort, quick visual recovery, and a rapid return to normal activities. Because MIGS avoids many risks associated with traditional surgery, such as excessive scarring, prolonged inflammation, and vision-threatening complications, patient satisfaction is often high, especially when their need for daily eye drops is reduced or eliminated.
Types of MIGS Procedures
Several MIGS options are available, each targeting specific aspects of eye fluid drainage to lower pressure effectively. Your eye care team will recommend the procedure best suited to your unique anatomy, glaucoma severity, and treatment goals.
The iStent Inject consists of two tiny titanium stents, among the smallest medical devices implanted in the human body, placed into the eye's natural drainage channels called Schlemm's canal. This quick procedure, often done during cataract surgery, helps improve fluid outflow by bypassing the blocked trabecular meshwork. Many patients experience sustained pressure reduction and can reduce reliance on glaucoma medications.
The Hydrus Microstent is a flexible, crescent-shaped scaffold made of a special nickel-titanium alloy that is designed to support and open a wider section of the eye's natural drainage canal compared to smaller stents. It spans approximately 90 degrees of Schlemm's canal, providing broader access for fluid drainage. It is particularly effective for mild to moderate open-angle glaucoma, with many patients experiencing sustained pressure reduction and decreased medication needs.
The Xen Gel Stent is a soft, flexible tube made of a special gelatin material that creates a new drainage pathway from inside the eye to the space beneath the conjunctiva, the clear tissue covering the white part of your eye. Unlike traditional filtering surgeries, the Xen uses a tiny injector and requires only a small incision. It is often used for moderate to advanced glaucoma or when other MIGS options are insufficient, and recovery is typically faster than traditional filtering procedures.
This procedure uses a handheld electrosurgical device with a tiny probe to precisely remove a strip of the eye's blocked trabecular meshwork tissue. By clearing away the obstruction without placing an implant, it restores the eye's natural ability to drain fluid through the remaining healthy drainage system. It is particularly effective for patients with primary open-angle glaucoma and can be performed alone or combined with cataract surgery.
This technique uses a specially designed surgical blade with a unique dual-blade design to make precise cuts in the trabecular meshwork, cleanly removing the blocked tissue without leaving behind debris that could cause scarring or re-obstruction. The innovative blade design allows for controlled, reproducible tissue removal. It can be performed alone or combined with cataract surgery, offering flexibility and consistently low complication rates.
ECP uses a laser probe inserted through a small incision to treat the ciliary body, the tissue inside your eye responsible for producing aqueous humor. The laser energy selectively reduces the fluid-producing cells, thereby lowering the amount of fluid created and subsequently reducing eye pressure. This technique can be particularly effective when combined with cataract surgery and is useful for various types of glaucoma, including cases where drainage enhancement alone may not be sufficient.
Benefits and Risks of MIGS
MIGS offers significant advantages for glaucoma management, but like any medical procedure, it carries potential risks that should be carefully considered. Understanding both sides helps you make confident, informed decisions about your treatment with your ophthalmologist.
Many MIGS patients can reduce or even eliminate their need for daily glaucoma medications after surgery. This is often a highly valued benefit, as eye drops can be expensive, inconvenient to use correctly, difficult to remember, and cause bothersome side effects like redness, stinging, blurred vision, or changes to the appearance of your eyelids and lashes. Reducing your medication burden can significantly improve your daily quality of life.
Most MIGS patients return to normal activities like driving, working, reading, and light household tasks within a week, compared to several weeks or months for traditional surgeries. You can typically resume light exercise within a few days and more strenuous activities within two to three weeks, though your doctor will provide specific guidelines based on your procedure and individual healing. This quicker recovery means less disruption to your life and work schedule.
MIGS procedures have significantly lower rates of serious complications like infection, bleeding inside the eye, vision-threatening pressure drops, or extensive scarring compared to traditional surgeries. The smaller incisions, gentler tissue handling, and preservation of normal eye anatomy reduce surgical trauma and promote faster, more predictable healing with fewer post-operative problems.
Because MIGS procedures are less invasive and do not create extensive tissue changes, scarring, or alterations to the eye's surface structures, they preserve your options for future treatments. If needed, additional MIGS procedures, laser treatments, or even traditional surgeries like trabeculectomy can still be performed later without compromising their effectiveness or safety.
MIGS procedures have an excellent safety record with very low rates of vision loss or serious complications. The procedures are performed under controlled conditions using high-magnification surgical microscopes, allowing for extreme precision and careful monitoring throughout the surgery.
While generally safe, potential complications can include temporary inflammation, a short-term spike in eye pressure immediately after surgery, minor bleeding in the front part of the eye, or temporary blurred vision. More serious but rare risks include infection, significant bleeding, device displacement or obstruction, excessive pressure lowering, or damage to surrounding eye structures. Your surgeon will discuss your individual risk profile before the procedure and answer any concerns you may have.
While MIGS is highly effective, it may not lower eye pressure as dramatically as more invasive traditional surgeries in cases of advanced or severe glaucoma. Some patients may still need to use one or more eye drops after surgery, though usually fewer than before. Understanding these realistic outcomes helps ensure satisfaction with your results.
Who is a Candidate for MIGS?
MIGS is particularly suited for patients with mild to moderate open-angle glaucoma who are not adequately controlled with medications alone or wish to reduce their medication burden. Candidacy depends on your type and severity of glaucoma, overall eye health, other medical conditions, and individual treatment goals.
Good candidates typically have primary open-angle glaucoma with mild to moderate optic nerve damage and eye pressure that is not well-controlled with medications alone or requiring multiple drops daily. Patients who have difficulty remembering to use eye drops consistently, experience significant side effects from medications, or want to reduce their long-term medication costs often make excellent candidates for MIGS.
Your doctor will review your complete medical history, current medications, and any allergies, then perform a detailed eye exam to evaluate your optic nerve damage using specialized imaging, assess visual field loss with computerized testing, measure your eye pressure at different times, and examine the anatomy of your eye's drainage angle using a special lens. This comprehensive evaluation helps determine which MIGS procedure would be most effective and safe for your specific situation.
If you have both glaucoma and cataracts, combining MIGS with cataract surgery is often an ideal approach. This strategy addresses both conditions in a single procedure, provides convenience with one surgery and recovery period, and often results in excellent outcomes for both vision clarity and pressure control. Many patients find this combined approach particularly appealing.
Your commitment to follow-up care and long-term monitoring is important for sustained success. Patients who want to maintain an active lifestyle, travel frequently, or have demanding work schedules often appreciate the quicker recovery and reduced medication burden that MIGS offers compared to more invasive surgeries or lifelong dependence on multiple daily eye drops.
MIGS might not be recommended if you have severe or advanced glaucoma with extensive optic nerve damage requiring very low target pressures, certain types of secondary glaucoma that need different treatment approaches, significant scarring or abnormal anatomy from previous eye surgeries or trauma, or narrow-angle or angle-closure glaucoma without proper preparation. These cases may require more aggressive traditional surgical approaches or combination treatments to achieve adequate pressure reduction and prevent further vision loss.
It is important to have realistic expectations about what MIGS can achieve. MIGS aims to lower eye pressure to a safer range and reduce medication use, but it is not a cure for glaucoma. The disease still requires ongoing monitoring even after successful surgery. Open, honest communication with your eye care team about your goals, concerns, and lifestyle needs is a key part of successful glaucoma management and treatment planning.
What to Expect During and After MIGS
Understanding the MIGS process from start to finish can help reduce anxiety and ensure the best possible outcome. Most patients find the experience more comfortable and straightforward than they initially expected, with minimal disruption to their daily lives.
Your doctor will perform comprehensive testing including detailed eye pressure measurements, optic nerve imaging, visual field testing, and examination of your drainage angle anatomy. You will receive detailed instructions about which medications to continue or temporarily stop, guidelines about eating and drinking before surgery, and what to bring on surgery day. You must arrange for a responsible adult to drive you home, as you will not be able to drive immediately after the procedure due to the effects of anesthesia and dilating drops.
MIGS is usually performed in an outpatient surgery center or hospital setting with local anesthesia using numbing drops and an injection around the eye, along with mild intravenous sedation to help you relax and remain comfortable throughout the procedure. You will be awake but drowsy and pain-free. The actual procedure is relatively quick, typically taking 15 to 45 minutes depending on the specific technique used and whether it is combined with cataract surgery. You will lie comfortably on your back while the surgeon works using a high-powered surgical microscope.
After your procedure, you will rest in a recovery area for 30 to 60 minutes while the staff monitors your eye pressure and overall condition. Your eye may be covered with a protective shield, and you will receive detailed written instructions about post-operative care. Most patients experience minimal discomfort and can go home the same day once they are stable and have been cleared by the surgical team.
After MIGS, you may experience mild discomfort or a scratchy sensation, some blurred vision that improves over the first few days, sensitivity to light, mild redness, or slight tearing for a few days. These symptoms are normal and typically resolve quickly. You will use prescribed antibiotic eye drops to prevent infection and anti-inflammatory drops to reduce swelling and promote healing. It is critically important to attend all scheduled follow-up visits so your doctor can monitor your healing, check your eye pressure, and adjust your treatment plan if needed.
To ensure a smooth recovery and the best possible outcome, please follow these important guidelines:
- Use all prescribed eye drops exactly as directed, at the correct times and in the proper order if using multiple drops.
- Avoid rubbing, touching, or pressing on your eye, which could displace the implant or introduce infection.
- Wear a protective eye shield at night for the first week if recommended by your surgeon.
- Keep water, soap, and shampoo out of your eye for at least one week, and avoid swimming, hot tubs, or submerging your head underwater.
- Refrain from heavy lifting over 25 pounds, strenuous exercise, or activities that could jar your head for at least one to two weeks.
- Avoid dusty or dirty environments that might increase infection risk during the early healing period.
- Attend all scheduled follow-up appointments, typically at one day, one week, one month, and three months after surgery.
- Contact your provider immediately if you experience severe pain not relieved by over-the-counter medication, sudden vision loss or significant worsening, increasing redness or swelling, flashing lights or new floaters, or any signs of infection like discharge or fever.
Even after a successful MIGS procedure, glaucoma requires lifelong monitoring because it is a chronic, progressive condition. Regular visits every three to six months allow your eye care team to check your eye pressure at different times of day, monitor your optic nerve health with specialized imaging to detect any subtle changes, assess your visual field for any new areas of damage, and adjust your treatment plan if needed. This ongoing care ensures your vision remains protected for years to come and allows for early intervention if any problems develop.
Frequently Asked Questions
Here are answers to some common questions patients have about MIGS. We encourage you to discuss any other questions or concerns with your eye care team at ReFocus Eye Health Cheshire.
MIGS procedures are designed to be comfortable and virtually pain-free. Local anesthesia with numbing drops and an injection completely numbs your eye, so you may feel slight pressure or awareness of touch but no sharp pain during surgery. Afterward, most patients experience only mild discomfort, scratchiness, or a foreign body sensation that can be managed with over-the-counter pain relievers like acetaminophen or ibuprofen if needed.
Most patients notice significant improvement in comfort and vision within the first few days to one week and can return to normal activities like reading, computer work, and light household tasks within a few days. Full healing of the surgical site typically occurs within four to six weeks, though you should avoid heavy lifting, strenuous exercise, swimming, and contact sports initially as advised by your surgeon to prevent complications.
No, MIGS cannot cure glaucoma, but it can effectively manage the condition by lowering eye pressure to a safer level and slowing or halting its progression. Glaucoma is a chronic, lifelong condition caused by progressive optic nerve damage that requires ongoing monitoring, regular eye exams, and continued care even after successful surgery. The goal of treatment is to preserve your remaining vision and prevent further loss.
Yes, several alternatives exist depending on your specific situation. Options include prescription eye drops in various classes that lower pressure through different mechanisms, oral medications like carbonic anhydrase inhibitors, laser treatments such as selective laser trabeculoplasty (SLT) or argon laser trabeculoplasty (ALT), and traditional filtering surgeries like trabeculectomy or glaucoma drainage device implantation. The best choice depends on your specific type and stage of glaucoma, other eye conditions, overall health, lifestyle factors, and treatment goals.
Studies show MIGS often provides more consistent and stable eye pressure control than eye drops alone, especially for patients who struggle with medication compliance, experience significant side effects, or require multiple drops daily. For many patients, MIGS reduces average eye pressure by 20 to 30 percent and allows elimination or reduction of glaucoma medications, making it a more reliable and convenient long-term solution than drops alone.
Yes, in many cases MIGS procedures can be repeated or additional MIGS devices can be implanted if eye pressure rises again over time. The minimally invasive nature of MIGS preserves the eye's structures and does not create the extensive scarring or tissue changes that would prevent future procedures. If MIGS is insufficient, you can also move to other treatments including laser therapy or traditional surgery.
MIGS is considered very safe for older adults and is commonly performed in patients over 65 and even into their 80s and 90s. The gentler approach, smaller incisions, lower complication rates, and faster recovery make it particularly well-suited for seniors who may not tolerate more extensive surgeries as well due to other health conditions or who want to minimize recovery time and disruption to their daily routines.
Additional FAQs
Absolutely. Regular eye exams remain essential after MIGS to monitor your glaucoma and ensure the treatment continues working effectively over the long term. These visits allow your doctor to check your eye pressure, examine your optic nerve for any changes, test your visual field for progression, and adjust your treatment plan if needed. Ongoing monitoring helps catch any changes early and protects your vision for life.
Maintaining a healthy lifestyle with regular moderate exercise like walking or swimming, eating a balanced diet rich in leafy greens and omega-3 fatty acids, staying well-hydrated, and protecting your eyes from injury with safety glasses when appropriate all support good outcomes. Managing other health conditions like diabetes, high blood pressure, and sleep apnea is also very important for your overall eye health and glaucoma control. Avoiding smoking and limiting caffeine intake may also be beneficial.
No, MIGS does not negatively impact cataract surgery outcomes. In fact, combining both procedures in a single surgery often provides excellent results for both vision clarity and glaucoma control, with the added convenience of a single surgery date, one recovery period, and often better insurance coverage. Many patients report high satisfaction when both conditions are addressed together.
Most patients can resume driving within a few days to one week after MIGS, once their vision has cleared sufficiently, they are no longer using narcotic pain medications if any were prescribed, and they feel comfortable and safe behind the wheel. Your doctor will evaluate your vision at follow-up visits and let you know specifically when it is safe to drive based on your individual recovery and visual function.
Most insurance plans, including Medicare and major private insurers, cover medically necessary MIGS procedures when appropriate criteria are met, such as documented glaucoma with inadequate control on medications or intolerance to medications. However, coverage details, prior authorization requirements, and out-of-pocket costs can vary significantly by insurance provider, specific plan, and the exact procedure performed, so it is always wise to check with your insurance company beforehand and obtain pre-authorization to avoid unexpected costs.
If MIGS does not provide sufficient pressure reduction to meet your target eye pressure or if glaucoma continues to progress despite MIGS, additional treatments can be added or performed. These might include resuming or adding glaucoma eye drops, undergoing laser therapy like selective laser trabeculoplasty, performing another MIGS procedure with a different device or technique, or moving to traditional filtering surgery like trabeculectomy or tube shunt implantation. Your eye care team will work closely with you to find the most effective approach for your individual situation.
Taking the Next Step
If you have glaucoma or are at risk, discussing MIGS with our ophthalmologists at ReFocus Eye Health Cheshire can help you understand all your treatment options and create a personalized plan for your eye health. Early intervention and appropriate treatment can make a significant difference in preserving your vision and maintaining your quality of life for years to come.
Very kind, caring and compassionate people. Kudos to you all!
Mary B
The whole process was seamless. Everyone is very competent and Dr Swan was great. He explained his findings to me in detail. I scheduled my next appointment without hesitation.
Joseph Langdeau
Dr. Swan is very thorough and takes the time to answer all my questions, which is important to me. The whole eye exam process is very smooth. I recommend this office!
Frank Minichiello
Dr. White and the staff at the Refocus Eye Cheshire location were extremely thorough and knowledgeable in explaining the cataract surgery procedure.
Joe Mos
Dr. Masi is an excellent and compassionate physician. Highly recommend!
Lee Tonge
Contact Us
Tuesday: Array
Wednesday: Array
Thursday: Array
Friday: Array
Saturday: Array
Sunday: Array